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Abstract
Background:  Laryngoscopy  and  endotracheal intubation can cause increase in sympathetic activity and simpatoadrenal reflex,
associated  with  increased  blood pressure and heart rate. The objective of this study was to compare the effects of dexmedetomidine
0.75 µg kgG1 b.wt., and fentanyl 2 µg kgG1 b.wt., to propofol induction dose requirement and hemodynamic response due to laryngoscopy
and endotrakheal intubation.  Materials and Methods:  Randomized, single-blind controlled study, involving 48 patients with ASA
physical status I and II planned for elective surgery with general anesthesia in DR (Wahidin Sudirohusodo hospital). Subjects are divided
into two groups and each group is given dexmedetomidine (D) 0.75 µg kgG1 b.wt. or fentanyl (F) 2 µg kgG1 b.wt. intravenously before
induction of  propofol  (50 mg kgG1 hG1) until the BIS reached 48±2, continued administration of atracurium 0.5 mg kgG1  and maintenance
with  1.0  vol%  isoflurane  in  oxygen  60%. Systolic and diastolic blood pressure, mean arterial pressure and heart rate are recorded at
1, 3 and 5 min after intubation as well as side effects. Results: Induction dose requirement in D group was less than the F group (p<0.05).
In the 1st min, there is a 16.32% increase in average MAP and 18.88% in mean heart rate in F group, whereas a 2.90% increase in average
MAP and 3.37% decrease of average heart rate was observed in D group. In the 3rd and 5th min, both groups were able to prevent
increase in blood pressure but the F group has not been able to prevent an increase in average heart rate at the 3rd min (3.99% increase).
The  incidence  of hypertension and tachycardia were significantly different (p<0.05) between the two groups.  Conclusion: Induction
dose requirement in dexmedetomidine group is less than the fentanyl group (p<0.05). Hemodynamic response on dexmedetomidine
0.75 µg kgG1 b.wt., is more stable than fentanyl 2 µg kgG1 b.wt., at 1st min after intubation but at 3rd and 5th min after intubation both
groups can maintain stable hemodynamic response with a lower mean heart rate achieved by dexmedetomidine.
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INTRODUCTION
The airway management is absolutely controlled by all
the expert’s anesthesia. One of action airway management is
mostly done in the practice of anesthesia is laryngoscopy and
intubation trakhea. From observations and the existing show
that most of the operations or surgical procedures performed
under general anesthesia. Most of general anesthesia were
accompanied  by  action  laryngoscopy  and  intubation
trakhea1,2.
Action laryngoscopy and intubation were performed
immediately after induction of anesthesia with standard doses
can often lead to reflex sympathetic and simpatoadrenal
excessive, resulting in increased blood pressure, increased
heart rate and arrhythmia. The increased blood pressure
ranges from 40-50% and an increase in heart rate ranges from
20%. This response even only temporary, may be in a healthy
person, it was not dangerous but in patients who have had
previous risk factors such as hypertension, Coronary Artery
Disease (CAD), cerebrovasculer disease (CVD) and intracranial
aneurysm it may be dangerous1-4.
Various ways or techniques have been used to prevent or
reduce the hemodynamic response at the time of
laryngoscopy and intubation5. The ways or techniques, such
as: Deepening  of  anesthesia,  local  anesthetic  (lidocaine)
intravenous  or   topical,   opioids   (fentanyl   and  alfentanil),
β-adrenergic blockers, vasodilators (nitroglycerin and sodium
nitroprusside),  calcium  channel  antagonist (diltiazem) and
"2-adrenergic  agonists  (clonidine).  Every  ways have
advantages and disadvantages2,3,6,7.
Fentanyl is a synthetic opioid agonist phenyl pyridine
derivatives were often used as an effective addition to
reducing the hemodynamic response to the act of
laryngoscopy and intubation, also has several other
advantages  namely  as intraoperative analgesics. However,
the procurement of fentanyl was not without problems,
opioids are classified as narcotic drugs. As a consequence,
they  are  regulated  by international treaties and national
drug control policy and in Indonesia the availability of opioids
was limited. Therefore, to overcome the limitations of the
amount of fentanyl, it can be used other medications that can
reduce the hemodynamic response due to the actions
laryngoscopy and intubation, one of them was
dexmedetomidine.
Dexmedetomidine   is    the    drug    of     the     class   of
α2-adrenergic     agonist     that    has    an     affinity     to   the
α2-adrenoceptor 8 times stronger when compared with
clonidine, which can reduce catecholamine levels in plasma
and  to  withhold  the  release  of catecholamines, which have
properties sympatholytic, anxiolytics, sedatives and analgesia
relative more potent and selective than α2-adrenergic earlier.
Dexmedetomidine such as clonidine has been reported to
reduce the stress response simpatoadrenal effectively,
minimizing the hemodynamic response after laryngoscopy
and intubation and raise the hemodynamic stabilization
during operation. It is also able to suppress and lower the
intraocular pressure increase caused by the actions of
laryngoscopy and intubation7,8.
Besides having sympatholytic effects, anxiolytic, sedative 
and  analgesia,  dexmedetomidine  also  have the  effect  of
saving  anestesik  (anesthetic  sparing effect) where  it can 
reduce  the  need  for opioid intraoperatively. Sedation  and 
analgesia  produced  were  achieved without affecting the
respiratory and hemodynamic significance7-9.
Dexmedetomidine has been studied the use for
premedication with a dose of 0.3-0.6 µg kgG1 b.wt.,
intravenously  and 1.0 µg kgG1 b.wt., intramuscularly and it was
obtained the optimum effect. At a dose of 0.6 µg kgG1 b.wt.,
intravenously can reduce the hemodynamic response due to
intubation and at a dose of 1.0 µg kgG1 b.wt., intramuscularly
can reduce catecholamine and lower pentotal needs as much
as 17%10.
The  aim  of  this  study  to demonstrate  the effectiveness 
of  dexmedetomidine  in  reducing  the need for propofol
induction dose and lower the hemodynamic response due to
laryngoscopy and intubation endotrakhea.
MATERIALS AND METHODS
This study was conducted at the Installation Surgery
Center Dr. Wahidin Sudirohusodo Hospital, Makassar from
December, 2015 until the samples were met. This study was a
clinical trial by a single-blind randomized controled trial, with
the shape of the experimental design (pre and post-test
control group design). Variables consisted of independent
variables (dexmedetomidine 0.75 µg kgG1, fentanyl 2 µg kgG1),
the dependent variable (Needs induction doses, the
hemodynamic response (TDS, TDD, TAR, LJ)), moderating
variable n (general anesthesia with laryngoscopy and
intubation) and the control variables (age, BMI, ASA PS,
Mallampati).
The study was conducted on 48 people who have had an
explanation and agree to follow all study procedures,
measured systolic blood pressure (TDS), diastolic blood
pressure (TDD), mean arterial pressure (TAR) and heart rate (LJ)
as the basic data then further divided into 2 groups:
dexmedetomidine (0.75 mg kgG1 ) dissolved in NaCl 0.9% up
to    20    mL    and   given  over  10 min and group (F) fentanyl
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(2 mg kgG1 ) in a solution of NaCl 0.9% administered over 2 min
via syringe pump. Induction of anesthesia was using propofol
(50 mg kgG1 daysG1) via  syringe  pump  until the BIS value of
48±2 (calculated amount of propofol). Then given muscle
relaxants atracurium 0.5 mg kgG1  as facilities intubation and
3 min after administration of atracurium action laryngoscopy
and intubation endotrakhea made up for 30 sec, then
measuring and recording hemodynamic 1, 3 and 5 min after
intubation.
RESULTS
From the analysis in Table 1 and 2, it was not found
significant differences in baseline characteristics in both study
groups. Therefore, 48 characteristics of research subjects can
be expressed statistically homogeneous (p>0.05). Gender, ASA
PS and Mallampati analyzed by chi-square test, whereas age
and Body Mass Index (BMI) were analyzed using the Mann
Whitney test, in which the value of p<0.05 revealed significant
statistically.
The initial clinical characteristics of the sample in this
study were comprised of TDS, TDD, TAR and heart rate before
induction, which can be seen in Table 3. From the results it
shows that, there was no significant difference in initial clinical
hemodynamic characteristics from both study groups, so that
it can be expressed homogeneous statistically (p>0.05).
Needs of  propofol induction dose: Results of a study of the
needs  of  propofol  induction  in both groups depicted in
Table 4 and Fig. 1.
From the analysis of Table 4, there was a significant
difference for the needs dose of propofol induction in both
study groups (p<0.05). The initial clinical characteristics were
analyzed  using  Mann  Whitney  test,  in  which  the value of
p<0.05 were significant statistically.
Hemodynamic: The study of hemodynamics in each group for
each  measurement  time  were  described  in  Table  5  and 6.
From results, it was shown in Table 5 that there was a change
in the TAR in both groups. There was a rise TAR in both groups
1 min after intubation, where the greater increase occur in the
fentanyl group and the comparison between the two groups
was significant statistically (p<0.05). Further decline again at
3rd and 5th min after intubation, the average mean arterial
pressure (TAR) was lower than the average mean arterial
pressure (TAR) basal in both groups. There was a larger
increase in the fentanyl group 1 min after intubation, although
it has fallen back on the observation of 3 min after intubation,
TAR was remained higher in the fentanyl group than
dexmedetomidine   group   and   was   different  significantly
(p<0.05). There was no mean arterial pressure (TAR) difference
significance found significance (p>0.05) between the two
groups at 5 min after intubation.
Table 1: Comparison of proportions of gender, ASA PS and mallampati at the
second group 
Groups
------------------------------------------------------------
Dexmedetomidine (n = 24) Fentanyl (n = 24)
----------------------------------- ----------------------
Variables n % n % p-value
Gender
Male 9 37.5 12 50 0.561
Female 15 62.5 12 50
ASA PS
I 12 50 13 54.2  1.000
II 12 50 11 45.8
Mallampati
1 16 66.7 11 45.8 0.244
2 8 33.3 13 54.2
Data was presented as a percentage (%). Tested with chi-square test, p<0.05 was
significant.  Group  D:  Dexmedetomidine 0.75 µg kgG1 b.wt., group F: Fentanyl
2 µg kgG1 b.wt.
Table 2: Comparison distribution of age and IMT at both of the groups
Groups
-------------------------------------------------------------------------
Dexmedetomidine (n = 24) Fentanyl (n = 24)
----------------------------------- ----------------------------------
Variables Min Max Mean SD Min Max Mean SD p-value
Age (year) 18 54 35.04 10.06 17 50 38.62 11.36 0.253
IMT (kg mG2) 18.73 24 21.79 1.40 17.44 23.90 21.62 1.80 0.710
Data  was  presented  as  a percentage (%). Tested with chi-square test,
significant difference at p<0.05.  Group  D:  Dexmedetomidine  0.75 µg kgG1 b.wt.,
group F: Fentanyl 2 µg kgG1 b.wt.
Table 3: Characteristics of the initial clinical hemodynamic both for dexmedetomidine and fentanyl
Groups
--------------------------------------------------------------------------------------------------------------------------------------------------------
KD (n = 24) KF (n = 24)
---------------------------------------------------------------------- -------------------------------------------------------------------
Variables Minimum Maximum Mean SD Minimum Maximum Mean SD p-value
TDS (mmHg) 107 138 123.4 7.6 108 138 127.3 7.8 0.086
TDD (mmHg) 66 84 74.1 5.5 60 90 75.9 6.7 0.327
TAR (mmHg) 83 103 93.6 5.8 80 107 96.8 7.0 0.098
LJ (x/min) 68 92 83.3 7.4 62 95 79.5 9.3 0.357
Data  was  presented  in  the  form  of  Mean±SD  (standard  deviation).  Tested   with   Mann  Whitney  test,  p<0.05  was  signifincant. Group D: Dexmedetomidine
0.75 mg kgG1 b.wt., group F: Fentanyl 2 mg kgG1 b.wt., TDS: Systolic blood pressure, TDD: Diastolic blood pressure, TAR: Average of arterial pressure, LJ: Heart rate
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Fig. 1: Comparison   of  mean at needs induction propofol
dose in both groups. Data was presented in Mean±SD
(standard    deviation).     Dexmedetomidine    group 
KD  =   0.75   µg    kgG1    b.wt.,    KF:    Group    fentanyl
2 µg kgG1 b.wt.
Table 4: Comparison of propofol induction dose requirement in both groups
Dose of propofol induction (mg)
----------------------------------------------------------------------
Groups Minimum Maximum Mean SD IK (95%) p-value
1 (n = 24) 36 58 45.58 7.30 42.50-48.67 <0.001
2 (n = 24) 55 79 66.96 7.21 63.70-70.22 <0.001
Data   was    presented   in    Mean±SD    (standard    deviation).   Tested   by 
Mann     Whitney      test,      p<0.05       revealed       significant      difference.
Group 1: Dexmedetomidine µg kgG1 b.wt., group 2: Fentanyl 2 µg kgG1 b.wt.
Figure 2 shows that first there was an increase mean
arterial pressure (TAR) at 1 min after intubation, then
decreases to the observation of 3 and 5 min after intubation
and lower than the mean arterial pressure (TAR) basal value.
The increase in fentanyl group was higher than in the group
of dexmedetomidine 1 min after intubation. Although, mean
arterial  pressure  (TAR)  decreased in both groups during the
3 min after intubation but the chart mean arterial pressure
(TAR)  of  fentanyl  group located above the graph
dexmedetomidine during 3 min after intubation. Then 5 min
after intubation chart mean arterial pressure (TAR) of both
groups coincide.
From the  results,  it was shown in Table 6 that there was
a change in both of the groups. There was heart rate (LJ)
increasing trend in the fentanyl group 1 min after intubation
and then fell back at 3rd and 5th min after intubation, whereas
in the group dexmedetomidine there was no increase and
even tends lower than heart rate (LJ) basal and more
decreased at 3rd and 5th min after intubation. There were
significant difference (p<0.05) after intubation at the both of
the groups. Rate of heart at fentanyl group was higher than
dexmedetomidine group at each time of observation.
Figure 3 shows that first there was an increase mean
arterial pressure (TAR) 1 min after intubation in the fentanyl
group and then decline steeply up to the observation of 3 min
and  remained  decreased  5  min after intubation with ramps
Table 5: Comparison of the mean arterial pressure at the both of the groups in time of measurement
Mean arterial pressure (mmHg)
Time of --------------------------------------------------------------------------------------------------------------------------
measurement Groups Minimum Maximum Mean SD IK (95%) p-value
To 1 (n = 24) 83 103 93.6 5.8 91.2-96.1 0.098
2 (n = 24) 80 107 96.8 7.0 93.8-99.7
T1 1 (n = 24) 85 103 96.2 5.2 94.0-98.4 <0.001
2 (n = 24) 98 137 112.2 10.2 107.9-116.5
T2 1 (n = 24) 80 100 89.3 5.4 87.0-91.5 0.005
2 (n = 24) 80 108 94.5 7.0 91.6-97.5
T3 1 (n = 24) 77 96 84.7 4.7 82.7-86.7 0.714
2 (n = 24) 76 96 85.3 6.2 82.6-87.9
Data  was  presented  in   Mean±SD   (standard   deviation).   Tested   by   Mann   Whitney  test,  p<0.05  revealed significant difference. Group 1: Dexmedetomidine
0.75 µg kgG1 b.wt., group 2: Fentanyl 2 µg kgG1 b.wt.. To: Measurement time before grouped, T1: Measurement time of 1 minute after intubation, T2: Measurement time
3 min after intubation, T3: Measurement time 5 min after intubation
Table 6: Comparison heart rate at both of the groups in time of measurement
Heart rate (x/min)
Time of ------------------------------------------------------------------------------------------------------------------------
measurement Groups Minimum Maximum Mean SD IK 95(%) p-value
To 1 (n = 24) 68 92 83.3 7.4 79.2-85.5 0.357
2 (n = 24) 62 95 79.5 9.3 75.6-83.5
T1 1 (n = 24) 68 86 79.3 5.2 77.1-81.5 <0.001
2 (n = 24) 82 119 93.7 8.7 90.0-97.3
T2 1 (n = 24) 64 77 70.5 3.6 87.0-91.5 <0.001
2 (n = 24) 70 104 82.2 8.3 78.7-85.7
T3 1 (n = 24) 59 72 64.5 3.6 82.7-86.7 <0.001
2 (n = 24) 65 98 77.7 7.6 74.4-80.9
Data was presented in    Mean±SD   (standard   deviation).   Tested   by  Mann  Whitney  test,  p<0.05  revealed  significant  difference.  Group  1: Dexmedetomidine
0.75 µg kgG1 b.wt., group 2: Fentanyl 2 µg kgG1 b.wt. To:  Measurement time before grouped, T1: Measurement time of 1 min after intubation, T2: Measurement time
3 min after intubation, T3: Measurement time 5 min after intubation
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Fig. 2: Dynamics of mean arterial pressure (TAR) in both groups. Data was presented in Mean±SD (standard deviation). Group
D: Dexmedetomidine 0.75 µg kgG1 b.wt., group F: Fentanyl 2 µg kgG1 b.wt.
Fig. 3: Dynamics   of    heart    rate    (LJ)    in    both    groups.    Data    was    presented   in   Mean±SD   (standard   deviation).
Group D: Dexmedetomidine 0.75 µg kgG1 b.wt., group F: Fentanyl 2 µg kgG1 b.wt.
and  slightly  lower  than  the  basal   value.   In   the   group  of
dexmedetomidine there was no increase and even tends to
decrease at 1 min after intubation and decreased more steeply
3 min after intubation and remained decreased to 5 min after
intubation.
From the analysis, it can be seen from Table 7, at 1 min
after intubation obtained percentage increase mean arterial
pressure (TAR) in the fentanyl group (16.32%) was higher than
the percentage increase mean arterial pressure (TAR) at the
dexmedetomidine group (2.90%) and it shows the difference 
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Table 7: Comparison changes percentages mean arterial pressure (TAR) to basal mean arterial pressure (TAR)
Average changes of TAR (%)
Time of --------------------------------------------------------------------------------------------------------------------------
measurement Groups Minimum Maximum Mean Standard deviation IK (95%) p-value
T1 1 (n = 24) -7.29 12.05 2.90 5.49 0.58-5.220 <0.001
2 (n = 24) 4.04 38.37 16.32 10.90 11.71-20.92
T2 1 (n = 24) -13.98 9.64 -4.47 6.36 -7.15-(-1.38) 0.261
2 (n = 24) -20.00 21.18 -1.81 9.82 -5.96-2.330
T3 1 (n = 24) -19.79 0.00 -9.46 3.80 -11.06-(-7.85) 0.103
2 (n = 24) -28.04 12.94 -11.40 9.56 -15.43-(-7.36)
Data was presented in of  Mean±SD  (standard  deviation).   Tested   by   Mann   Whitney  test,  p<0.05  revealed  significantly difference. Group 1: Dexmedetomidine
0.75 75 µg kgG1 b.wt., group 2: Fentanyl 75 µg kgG1 b.wt., To:  Measurement time before grouped, T1: Measurement time of 1 min after intubation, T2: Measurement
time 3 min after intubation, T3: Measurement time 5 min after intubation
Table 8: Comparison of percentage heart rate (LJ) changes to heart rate (LJ) basal
Changes of heart rate (%)
Time of ---------------------------------------------------------------------------------------------------------------------------
measurement Groups Minimum Maximum Mean SD IK (95%) p-value
T1 1 (n = 24) -11.76 5.26 -3.37 5.11 -5.53-1.21 <0.001
2 (n = 24) 2.47 57.58 18.88 14.41 12.79-24.96
T2 1 (n = 24) -25.58 5.88 -13.87 7.00 -16.82-(-10.91) <0.001
2 (n = 24) -13.58 35.48 3.99 10.43 -0.41-8.39
T3 1 (n = 24) -31.03 -7.25 -21.22 6.35 -23.90-(-18.53) <0.001
2 (n = 24) -14.77 25.81 -1.64 10.36 -6.01-2.73
Data was presented in of  Mean±SD  (standard  deviation).  Tested  by  Mann  Whitney  test,  p<0.05  revealed   significantly difference.   Group   1:  Dexmedetomidine
0.75 µg kgG1 b.wt., group 2: Fentanyl µg kgG1 b.wt., To: Measurement time before grouped, T1: Measurement time of 1 min after intubation, T2: Measurement time
3 min after intubation, T3: Measurement time 5 min after intubation
Table 9: Incidence of side effect of both of the groups for dexmedetomidine and
fentanyl
Groups
--------------------------------------------------------------
Dexmedetomidine (n = 24) Fentanyl (n = 24)
----------------------------------- ------------------------
Incidences n % n % *p-value
Hypertension - - 5 20.83 <0.001
Hypotension - - - -
tachycardia - - 5 20.83
Bradycardia - - - -
Nauseous vomit - - - -
Data was presented as a percentage (%). *Tested with chi-square test, p<0.05
revealed  significantly  difference.  Dexmedetomidine  group  KD:  µg  kgG1 b.wt.,
KF: Group of fentanyl  µg kgG1 b.wt.
significance  (p<0.05).  When  viewed  in the lowest and
highest value column, on the fentanyl group all increases
ranging  from  4.04-38.37%,  whereas  in  group  of
dexmedetomidine were ranging from -7.29 to 12.05%. It
means that in this group, there are not all experiencing an
increase, there was some decline. The highest increase is
12.05% and the highest decrease is 7.29%.
 At  3  min  after  intubation  obtained  a percentage
reduction mean arterial pressure (TAR) in fentanyl group
(1.81%) and  mean percentage  reduction  mean  arterial
pressure  (TAR)  in  dexmedetomidine   group   (4.47%)  and
this  difference    indicates    a    significant    difference
(p>0.05).
At 5 min after intubation obtained a mean percentage
reduction mean arterial pressure (TAR) in fentanyl group
(11.40%)  and a percentage reduction mean arterial pressure
(TAR) in dexmedetomidine group (9.46%) and this difference
indicates a significant difference (p>0.05).
From the analysis  results,  it  was  shown  in  Table   8,  at
1 min after intubation percentage average of heart rate
increase in the fentanyl group was higher (18.88%) of the
average heart rate basal, while the average percentage of
heart rate on dexmedetomidine group decreased (3.37%). At
3 min after intubation average of the percentage decreased
from previously (3.99%) even though they increased from
basal  of  heart  rate,  whereas  the average percentage of
heart  rate  on  group  of  dexmedetomidine  decrease
(13.87%).  At  5  min  after intubation both group of
dexmedetomidine and fentanyl group decrease heart rate
mean, wherein the fentanyl group  decreased  (1.64%)  and 
dexmedetomidine   (21.22%).
Incidence of side effect: From the results in Table  9, in this
study only found the incidence of side effects of hypertension
and tachycardia. For group of dexmedetomidine was not
encountered any adverse experiences, while in the fentanyl
group there were 5 patients (20.83%) who had hypertension
and 5 patients (20.83%) who experienced tachycardia. So
statistically significant difference (p<0.05) for the incidence of
adverse events in both groups in this study. Comparison of the
incidence of adverse events in both groups were analyzed
using chi-square test, in which the probability value p<0.05
revealed statistically significant.
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DISCUSSION 
The use of induction supplements drugs aim to reduce
the hemodynamic response due to intubation laryngoscopy
actions have been carried out by experts. Some medications
that are often used include: local anesthetics (lidocaine)
intravenous or topical opioids (fentanyl), $-adrenergic
blockers, vasodilators (nitroglycerin, sodium nitroprusside),
calcium  channel  antagonist  (diltiazem),  "2-adrenergic
agonists (Dexmedetomidine) and combinations of these
drugs. Dexmedetomidine are new drugs that some experts
have been used to suppress hemodynamic response due to
the actions laryngoscopy and intubation, while fentanyl was
the most  commonly  drug   that   used   in   the   Hospital  of
Dr.  Wahidin  Sudirohusodo Makassar. The aim of the study
was  comparing  the  efficacy  among of both of the drugs11-16.
In the group of dexmedetomidine, it was seen that the
needs  of  the  propofol  induction  dose was significantly
lower compared to the fentanyl group. This was caused
dexmedetomidine has sedative effects that study on
sureleuspontine locus, which is an important source of the
sympathetic nervous system that innervate forebrain and vital
modulator of vigilance system17.
In the 1st min after intubation group of fentanyl was not
able to prevent the increase in blood pressure and heart rate
due to laryngoscopy and intubation action, otherwise the
group dexmedetomidine was effective. Obtained in the
fentanyl group, mean arterial pressure (TAR) rose as much as
16.32% of mean arterial pressure (TAR) basal and mean heart
rate (LJ) increased by 18.88% from basal of heart rate (LJ),
while the mean arterial pressure (TAR) at dexmedetomidine
rose as much as 2.90% of the mean arterial pressure (TAR)
basal and average heart rate (LJ) decreased by 3.37% of the
basal  of  heart   rate.   This  was  consistent  with  study of
Kallio et  al.11,  which    reported   that   dexmedetomidine  as
"2-adrenoceptor agonists can be used to control perioperative
hemodynamics, there was significant reduction in the blood
pressure and heart rate, depending on the dose given. In the
3 min, both groups of dexmedetomidine and fentanyl group
was able to prevent the increase in blood pressure, it seems
that the mean arterial pressure (TAR) of fentanyl group
decreased as much as 1.81% and the mean arterial pressure
(TAR) of group  dexmedetomidine decreased as much as
4.47% from the mean arterial pressure (TAR) basal but the
fentanyl group has not been able to prevent an increase in
heart rate which is still an increase in the average of heart rate
3.99% of basal of heart rate. In contrast to the average heart
rate decline in the group of dexmedetomidine as much as
13.87% of heart rate basal17-23.
In  the 5 min  after  intubation  both dexmedetomidine
group and fentanyl group decreased hemodynamic response
in all variables. Where in the fentanyl group there was
decrease mean arterial pressure (TAR) as much as 11.40% of
the T mean arterial pressure (TAR) basal and decrease heart
rate as much as 1.64% of the basal heartrate.  While the
decline mean arterial pressure (TAR) in the average group of
dexmedetomidine as much as 9.46% of TAR basal and
decrease the average of heart rate as much as 21.22% of heart
rate basal24,25.
Thus it can be said that dexmedetomidine was effective
in reducing the increase in the hemodynamic response due to
the actions laryngoscopy and intubation compared to
fentanyl. Although less effective, fentanyl can also be used to
reduce the increase in the hemodynamic response due to the
actions laryngoscopy and intubation, because fentanyl was
able   to   suppress   hemodynamic   response   in   the  3 and
5  min.  Theory  says  that  in  healthy   people   there   was  an
increase in  blood  pressure  both systolic and diastolic
occurred from 5 sec, reaching a peak in 1-2 min and again like
before laryngoscopy in 5 min. The inceease of TDS mean more
than 53  mmHg,  TDD  was  more than 34 mmHg and heart
rate13, 26-28  more than 23 beats minG1.
Hemodynamic response between the two groups differed
significantly on all the variables in the 1 min. Statistically,
dexmedetomidine  was  more effective  than fentanyl in
preventing an increase in the hemodynamic response to the
laryngoscopy and intubation  action.  This  was because
dexmedetomidine  "2-adrenergic  receptors  activate
presynaptic which will inhibit neurotransmitter release in the
end of nerves and cause a decrease in plasma norepinephrine
levels that produce cardiovascular stabilization. Fentanyl
although  less  effective  but  it  can also decrease the
hemodynamic response with the procedure blocking pain
stimuli, depressed central sympathetic tone and activation of
vagal tone29.
Previous studies either on dexmedetomidine or fentanyl
generally produce the same results on the blood pressure
response, where dexmedetomidine was effective, while
fentanyl was less effective in reducing blood pressure due to
laryngoscopy   and   intubation.   Appropriate  study  of
Kharwar   et   al.12,    which     states    that    dexmedetomidine
1 µg kgG1 b.wt., was more effective in reducing the
hemodynamic  response  due  to  the laryngoscopy and
intubation compared with fentanyl 2 µg kgG1 b.wt., but side
effects  such  as  hypotension  and  bradycardia commonly
occurst12,30.
In the 5 min there were decreased hemodynamic
response in both groups, which differ significantly decrease in
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all variables except the variable of heart rate were not
significantly different in the fentanyl group. The decline was
bigger and stronger in dexmedetomidine group, even decline
to below the initial value of all variables. Blood pressure and
heart rate was more quickly descended on the group of
dexmedetomidine caused by the effects of the central
sympathetic tone depression from dexmedetomidine that
produce vasodilation and decrease heart rate. Impairment to
below the initial value occurs because until the 5 min the
surgery have not been conducted, so in accordance with the
theory that after the 1 min of the value will come down by
itself and  reach  the  initial  value  after  the 5 min17,18,31,32.
The incidence of hypertension and tachycardia obtained
in the two groups was significantly different (p<0.05), in which
5 people (20.83%) hypertension and 5 people (20.83%) in the
group  of  fentanyl  experienced tachycardia occurring in the
1 min, whereas in the group of dexmedetomidine was not
found. The incidence of hypotension and bradycardia in both
groups were found.
CONCLUSION
The needs dose of profol induction was less on
administration dexmedetomidine 0.75 µg kgG1 b.wt.,
compared to the administration of fentanyl 2 µg kgG1 b.wt., in
patients who undergoing general anesthesia procedures.
Dexmedetomidine hemodynamic response in the
administration of µg kgG1 b.wt., was more stable than
administration offentanyl 2 µg kgG1 b.wt., at 1 min after
intubation.
Both of  dexmedetomidine 0.75 µg kgG1 b.wt. and fentanyl
2 µg kgG1 b.wt., can maintain stable response of hemodynamic
at 3 and 5 min after intubation but the average heart rate at
dexmedetomidine administration was lower.
SIGNIFICANCE STATEMENTS
In surgery procedure, laryngoscopy and endotracheal
intubation can cause the increase of blood pressure and heart
rate (hemodynamic indicators) due to the sympathetic activity
and simpatoadrenal reflex. This study aimed to compare the
capacity of dexmedetomidine and fentanyl in stabilize the
hemodynamic status. Fourty eight patients, involved in this
randomized, single-blind controlled study. Before induction
with propofol and intubation, 14 patients in group D received
dexmedetomidine 0.75 µg kgG1 b.wt. and the rest, group F,
received fentanyl 2 µg kgG1 b.wt.  The dose of propofol need
to reach BIS as well as blood pressure, mean arterial pressure
and heart rate were recorded at 1, 3 and 5 min after
intubation. This study showed intravenous dexmedetomidine
lowering induction dose of propofola, stabilize heart rate and
blood pressure better than fentanyl. This study cloncluded
that for patient who has heart problem, it is recommended to
give dexmedetomidine as premedication.
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